Comentarios Editoriales
Consideraciones sobre los análisis de subgrupos en los ensayos clínicos
Considerations on Subgroup Analyses in Clinical Trials
P. Coto-Segura
Unidad de Psoriasis, Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Asturias, España
Leído
6598
Vecesse ha leído el artículo
2181
Total PDF
4417
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 111 | 11 | 122 |
| 2025 5 | 152 | 28 | 180 |
| 2025 4 | 137 | 24 | 161 |
| 2025 3 | 145 | 22 | 167 |
| 2025 2 | 105 | 27 | 132 |
| 2025 1 | 80 | 32 | 112 |
| 2024 12 | 87 | 32 | 119 |
| 2024 11 | 120 | 45 | 165 |
| 2024 10 | 77 | 41 | 118 |
| 2024 9 | 68 | 25 | 93 |
| 2024 8 | 82 | 52 | 134 |
| 2024 7 | 80 | 26 | 106 |
| 2024 6 | 117 | 24 | 141 |
| 2024 5 | 79 | 35 | 114 |
| 2024 4 | 75 | 18 | 93 |
| 2024 3 | 59 | 33 | 92 |
| 2024 2 | 50 | 23 | 73 |
| 2024 1 | 78 | 24 | 102 |
| 2023 12 | 45 | 15 | 60 |
| 2023 11 | 62 | 32 | 94 |
| 2023 10 | 48 | 22 | 70 |
| 2023 9 | 41 | 26 | 67 |
| 2023 8 | 35 | 9 | 44 |
| 2023 7 | 50 | 31 | 81 |
| 2023 6 | 50 | 21 | 71 |
| 2023 5 | 84 | 23 | 107 |
| 2023 4 | 40 | 27 | 67 |
| 2023 3 | 58 | 32 | 90 |
| 2023 2 | 61 | 29 | 90 |
| 2022 1 | 51 | 24 | 75 |
| 2022 12 | 61 | 37 | 98 |
| 2022 11 | 70 | 44 | 114 |
| 2022 10 | 87 | 45 | 132 |
| 2022 9 | 61 | 52 | 113 |
| 2022 8 | 60 | 64 | 124 |
| 2022 7 | 59 | 42 | 101 |
| 2022 6 | 54 | 34 | 88 |
| 2022 5 | 56 | 53 | 109 |
| 2022 4 | 75 | 25 | 100 |
| 2022 3 | 73 | 54 | 127 |
| 2022 2 | 64 | 42 | 106 |
| 2021 1 | 64 | 64 | 128 |
| 2021 12 | 54 | 37 | 91 |
| 2021 11 | 64 | 33 | 97 |
| 2021 10 | 68 | 61 | 129 |
| 2021 9 | 46 | 38 | 84 |
| 2021 8 | 60 | 39 | 99 |
| 2021 7 | 42 | 36 | 78 |
| 2021 6 | 51 | 47 | 98 |
| 2021 5 | 75 | 63 | 138 |
| 2021 4 | 75 | 91 | 166 |
| 2021 3 | 79 | 27 | 106 |
| 2021 2 | 84 | 45 | 129 |
| 2020 1 | 52 | 23 | 75 |
| 2020 12 | 41 | 19 | 60 |
| 2020 11 | 60 | 29 | 89 |
| 2020 10 | 55 | 21 | 76 |
| 2020 9 | 51 | 19 | 70 |
| 2020 8 | 50 | 27 | 77 |
| 2020 7 | 44 | 23 | 67 |
| 2020 6 | 36 | 33 | 69 |
| 2020 5 | 32 | 28 | 60 |
| 2020 4 | 24 | 25 | 49 |
| 2020 3 | 35 | 23 | 58 |
| 2020 2 | 3 | 0 | 3 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 4 | 0 | 4 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 2 | 0 | 2 |
| 2019 7 | 5 | 0 | 5 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 4 | 0 | 4 |
| 2019 4 | 2 | 0 | 2 |
| 2019 2 | 3 | 0 | 3 |
| 2018 12 | 3 | 0 | 3 |
| 2018 11 | 2 | 0 | 2 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 3 | 0 | 3 |
| 2018 4 | 1 | 1 | 2 |
| 2018 2 | 4 | 0 | 4 |
| 2018 1 | 9 | 0 | 9 |
| 2017 12 | 12 | 2 | 14 |
| 2017 11 | 6 | 1 | 7 |
| 2017 10 | 5 | 0 | 5 |
| 2017 9 | 10 | 1 | 11 |
| 2017 8 | 8 | 6 | 14 |
| 2017 7 | 20 | 7 | 27 |
| 2017 6 | 3 | 4 | 7 |
| 2017 5 | 0 | 2 | 2 |
| 2017 4 | 0 | 1 | 1 |
Mostrar todo
